Tilray Reports Record Quarterly Revenue Despite Cannabis Sales Decline

• Tilray reported a record quarterly revenue of $257 million.
• Despite the record revenue, Tilray's cannabis sales have shrunk.
• Tilray is a major player in the cannabis industry, selling both medical and recreational products.
• The company has expanded its international operations and secured certifications to support its supply chain.
• The reasons for the decline in cannabis sales are not specified in the reports.